Cell-of-origin effects on development of colon cancer
起源细胞对结肠癌发展的影响
基本信息
- 批准号:8403775
- 负责人:
- 金额:$ 35.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAge-MonthsAllelesAnimalsCell physiologyCell surfaceCellsChromosomal StabilityColonColon CarcinomaColonic NeoplasmsColorectal CancerComplementary DNADevelopmentDigoxigeninDoseElementsEnvironmentEpidermal Growth Factor ReceptorEpithelialEventExhibitsGenesGeneticGenetically Engineered MouseGrowthHourIn VitroInjection of therapeutic agentInternal Ribosome Entry SiteKRAS2 geneLabelLeucineLeucine-Rich RepeatMalignant NeoplasmsMusNeoplasmsNeoplastic ProcessesPatternPhenotypePopulationPropertyRNA ProbesRegulationSignal TransductionSorting - Cell MovementStem cellsTamoxifenTertiary Protein StructureTestingTumor Stem Cell AssayXenograft procedurecancer cellcancer initiationcancer stem cellcell motilitycolonic crypthuman CCXCR1 receptorin vivoloss of functionmutantneoplastic cellnovelnovel therapeuticsprogenitorpublic health relevancerecombinaseresearch studyselective expressionstem cell populationtumortumor initiationtumor progression
项目摘要
DESCRIPTION (provided by applicant): It remains generally accepted that colorectal cancer (CRC) results from the accumulation of genetic events within the epithelial compartment. Unresolved issues include (1) whether the order of these genetic events matter (e.g., APC vs KRAS), (2) whether cancers can initiate from multiple distinct cells of origin, (3) the relationship between the normal colonic stem cell and the cells that function to maintain the tumor and (4) the contribution of the local environment to the neoplastic process. We hypothesize that colonic tumor initiation and progression is highly dependent upon the origin of the cell that incurs the relevant mutagenic events, as well as the regulation of growth and clonal selection of particular progeny that emanate from tumor-initiating cells. We have demonstrated that there are distinct normal colonic progenitor populations marked by expression of two specific cell surface markers, Lrig1 and Lgr5. Although the precise relationship between cells expressing these two markers is unknown, these two bona fide stem cell markers exhibit overlapping, yet distinct, expression patterns in both normal colon and in ApcMin/+ tumors. Of note, Lrig1 is induced by EGFR signaling and acts to negatively regulate EGFR signaling, whereas Lgr5 is a canonical Wnt target of unknown function. We have generated inducible Lrig1-CreERT2 mice, and our collaborator Hans Clevers has provided us with inducible Lgr5-EGFP-IRES-CreERT2 animals that allow for the specific activation of Cre recombinase within distinct colonic stem cell populations. We will use these mice to determine the importance of cell-of-origin in colon cancer initiation and progression. In addition, we have identified a gene, Slc26a3, that is selectively expressed in the differentiated compartment of the colon, and we have generated Slc26a3-CreERT2 mice that will allow us to resolve whether colonic tumors arise from the "top down" or "bottom up."
描述(由申请人提供):通常认为结直肠癌(CRC)是由于遗传事件在上皮室内的积累而产生的。未解决的问题包括(1)这些遗传事件的顺序是否重要(例如,APC与KRAS),(2)癌症是否可以从多个不同的原始细胞中引发,(3)正常的结肠干细胞与维持肿瘤功能的细胞和(4)局部环境对神经胶体过程的作用。我们假设结肠肿瘤的启动和进展高度取决于造成相关诱变事件的细胞的起源,以及对从肿瘤启动细胞中散发出的特定后代的生长和克隆选择的调节。我们已经证明,有两个特定细胞表面标记LRIG1和LGR5的表达标志着明显的正常结肠祖细胞种群。尽管表达这两个标记的细胞之间的精确关系尚不清楚,但这两个真正的干细胞标记物在正常结肠和APCMIN/+肿瘤中均显示出重叠但不同的表达模式。值得注意的是,LRIG1是由EGFR信号传导诱导的,并作用于负调控EGFR信号,而LGR5是未知功能的规范WNT目标。我们已经产生了诱导的LRIG1-CREERT2小鼠,我们的合作者Hans Clevers为我们提供了诱导的LGR5-EGFP-IRES-CREERT2动物,这些动物允许在不同的结肠干细胞群体中特异性激活CRE重组酶。我们将使用这些小鼠来确定原生蛋白在结肠癌开始和进展中的重要性。此外,我们已经确定了一个基因SLC26A3,该基因在结肠的分化区室中有选择地表达,并且我们产生了SLC26A3-Creert2小鼠,该小鼠将使我们能够解决结肠肿瘤是从“上下倒下”还是“下到底”。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert J. Coffey其他文献
Stereotactic drainage of Aspergillus brain abscess with long-term survival: case report and review.
曲霉菌脑脓肿的立体定向引流与长期生存:病例报告和回顾。
- DOI:
- 发表时间:
1989 - 期刊:
- 影响因子:4.8
- 作者:
Michael L. Goodman;Robert J. Coffey - 通讯作者:
Robert J. Coffey
Studies on uterine collagenase in tissue culture. II. Effect of steroid hormones on enzyme production.
组织培养子宫胶原酶的研究。
- DOI:
- 发表时间:
1971 - 期刊:
- 影响因子:0
- 作者:
John J. Jeffrey;Robert J. Coffey;A. Z. Eisen - 通讯作者:
A. Z. Eisen
Sa1613 - Expression of Lrig1, a Negative Regulator of Egfr, is Dynamically Altered in Different Stages of Gastric Carcinogenesis
- DOI:
10.1016/s0016-5085(18)31437-9 - 发表时间:
2018-05-01 - 期刊:
- 影响因子:
- 作者:
Hyunji Kim;Sungsook Yu;Yejin Cho;Robert J. Coffey;James R. Goldenring;Ki Taek Nam;Mijeong Yang;Keunwook Lee;Sang-Ho Jeong;Kyung-Min Lim - 通讯作者:
Kyung-Min Lim
Sa1629 - Testosterone-Dependent Differential Expression of Egfr in Male and Female Mice and Its Implications for Carcinogenesis and Treatment Response
- DOI:
10.1016/s0016-5085(18)31453-7 - 发表时间:
2018-05-01 - 期刊:
- 影响因子:
- 作者:
Won Jae Huh;Kathleen Rhoades;Robert J. Coffey - 通讯作者:
Robert J. Coffey
Antioxidant-induced association of CCAAT/enhancer-binding protein β (C/EBPβ) with an A-kinase anchoring protein multi-enzyme complex facilitates type II A-kinase-mediated phosphorylation and nuclear translocation of C/EBPβ
- DOI:
10.1016/s0016-5085(98)82354-8 - 发表时间:
1998-04-15 - 期刊:
- 影响因子:
- 作者:
Rebecca Chinery;Robert J. Coffey;Daniel T. Dransfield - 通讯作者:
Daniel T. Dransfield
Robert J. Coffey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert J. Coffey', 18)}}的其他基金
Integrative Single-Cell Atlas of Host and Microenvironment in Colorectal Neoplastic Transformation
结直肠肿瘤转化中宿主和微环境的综合单细胞图谱
- 批准号:
10820067 - 财政年份:2023
- 资助金额:
$ 35.41万 - 项目类别:
Shaping the Microenvironment by DPEP1 Facilitates Adenoma Progression
通过 DPEP1 塑造微环境促进腺瘤进展
- 批准号:
10518847 - 财政年份:2022
- 资助金额:
$ 35.41万 - 项目类别:
Shaping the Microenvironment by DPEP1 Facilitates Adenoma Progression
通过 DPEP1 塑造微环境促进腺瘤进展
- 批准号:
10697369 - 财政年份:2022
- 资助金额:
$ 35.41万 - 项目类别:
Role of WNT-EGFR crosstalk by EVs and exomeres in normal colon and colon cancer
EV 和外泌体 WNT-EGFR 串扰在正常结肠和结肠癌中的作用
- 批准号:
10544807 - 财政年份:2020
- 资助金额:
$ 35.41万 - 项目类别:
Project 1: Interrogating Distinct Tumor-Initiating Cells in CRC
项目 1:研究 CRC 中不同的肿瘤起始细胞
- 批准号:
10700848 - 财政年份:2019
- 资助金额:
$ 35.41万 - 项目类别:
Distribution of Molecular Features for Colorectal Cancers in Northern Tanzania
坦桑尼亚北部结直肠癌的分子特征分布
- 批准号:
10845027 - 财政年份:2019
- 资助金额:
$ 35.41万 - 项目类别:
相似国自然基金
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
- 批准号:12303035
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
- 批准号:42305193
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Hypothalamic Sleep-Wake Neuron Defects in Alzheimer’s disease
阿尔茨海默病中的下丘脑睡眠-觉醒神经元缺陷
- 批准号:
10770001 - 财政年份:2023
- 资助金额:
$ 35.41万 - 项目类别:
The impact of auditory access on the development of speech perception
听觉访问对言语感知发展的影响
- 批准号:
10677429 - 财政年份:2023
- 资助金额:
$ 35.41万 - 项目类别:
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
- 批准号:
10638439 - 财政年份:2023
- 资助金额:
$ 35.41万 - 项目类别:
mHealth OAE: Towards Universal Newborn Hearing Screening in Kenya (mTUNE)
mHealth OAE:迈向肯尼亚全民新生儿听力筛查 (mTUNE)
- 批准号:
10738905 - 财政年份:2023
- 资助金额:
$ 35.41万 - 项目类别:
Amnion cell secretome mediated therapy for traumatic brain injury
羊膜细胞分泌组介导的创伤性脑损伤治疗
- 批准号:
10746655 - 财政年份:2023
- 资助金额:
$ 35.41万 - 项目类别: